Mining viral proteins for antimicrobial and cell-penetrating drug delivery peptides

Bioinformatics

Volumn 31, Issue 14, 2015, Pages 2252-2256

  Freire, João Miguel ^a   Dias, Susana Almeida ^a   Flores, Luís ^a   Veiga, Ana Salomé ^a   Castanho, Miguel A R B ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CAPSID PROTEIN; CELL PENETRATING PEPTIDE; MEMBRANE PROTEIN; VIRUS PROTEIN;

CHEMISTRY; SEQUENCE ANALYSIS;

ANTI-INFECTIVE AGENTS; CAPSID PROTEINS; CELL-PENETRATING PEPTIDES; MEMBRANE PROTEINS; SEQUENCE ANALYSIS, PROTEIN; VIRAL PROTEINS;

EID: 84935853847     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btv131     Document Type: Article

References (47)

1. Abrescia, N. G. A. et al. (2012) Structure unifies the viral universe. Annu. Rev. Biochem., 81, 795-822.
2. Alves, C. S. et al. (2010) Escherichia coli cell surface perturbation and disruption induced by antimicrobial peptides BP100 and pepR. J. Biol. Chem., 285, 27536-27544.
3. Arias, C. F. (2013) Virus diversity and evolution. Curr. Opin. Microbiol., 16, 465-467.
4. Bateman, A. et al. (1999) Pfam 3. 1: 1313 multiple alignments and profile HMMs match the majority of proteins. Nucleic Acids Res., 27, 260-262.
5. Copolovici, D. M. et al. (2014) Cell-penetrating peptides: design, synthesis, and applications. ACS Nano, 8, 1972-1994.
6. Craik, D. J. et al. (2012) The future of peptide-based drugs. Chem. Biol. Drug Des., 81, 136-147.
7. de Figueiredo, I. R. et al. (2014) Cell penetrating peptides: A tool for effective delivery in gene-targeted therapies, IUBMB Life. doi:10. 1002/iub. 1257.
8. de Jong, A. et al. (2010) BAGEL2: mining for bacteriocins in genomic data. Nucleic Acids Res., 38, W647-W651.
9. Domingues, M. M. et al. (2009) rBPI21 promotes lipopolysaccharide aggregation and exerts its antimicrobial effects by (hemi)fusion of PG-containing membranes. PLoS One, 4, e8385.
10. Domingues, M. M. et al. (2014) Antimicrobial protein rBPI21-induced surface changes on Gram-negative and Gram-positive bacteria. Nanomedicine, 10, 543-551.
11. Douglas, T. and Young, M. (2006) Viruses: making friends with old foes. Science, 312, 873-875.
12. Falanga, A. et al. (2011) A peptide derived from herpes simplex virus type 1 glycoprotein H: membrane translocation and applications to the delivery of quantum dots. Nanomedicine, 7, 925-934.
13. Fox, J. L. (2013) Antimicrobial peptides stage a comeback. Nat. Biotechnol., 31, 379-382.
14. Frankel, A. D. and Pabo, C. O. (1988) Cellular uptake of the tat protein from human immunodeficiency virus. Cell, 55, 1189-1193.
15. Freire, J. M. et al. (2013) Intracellular nucleic acid delivery by the supercharged dengue virus capsid protein. PLoS One, 8, e81450.
16. Freire, J. M. et al. (2014) Nucleic acid delivery by cell penetrating peptides derived from dengue virus capsid protein: design and mechanism of action. FEBS J., 281, 191-215.
17. Freire, J. M. et al. (2015) Shifting gear in antimicrobial and anticancer peptides biophysical studies: from vesicles to cells. J. Pept. Sci., 21, 178-185.
18. Gautam, A. et al. (2012) CPPsite: A curated database of cell penetrating peptides. Database, 2012, bas015.
19. Gautam, A. et al. (2013) In silico approaches for designing highly effective cell penetrating peptides. J. Transl. Med., 11, 74.
20. Hammami, R. et al. (2010) BACTIBASE second release: A database and tool platform for bacteriocin characterization. BMC Microbiol., 10, 22.
21. Hiller, K. et al. (2004) PrediSi: prediction of signal peptides and their cleavage positions. Nucleic Acids Res., 32, W375-W379.
22. Huang, Y. et al. (2013) Curb challenges of the 'Trojan Horse' approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery. Adv. Drug Deliv. Rev., 65, 1299-1315.
23. Hulo, N. et al. (2008) The 20 years of PROSITE. Nucleic Acids Res., 36, D245-D249.
24. Hulo, C. et al. (2011) ViralZone: A knowledge resource to understand virus diversity. Nucleic Acids Res., 39, D576-D582.
25. Ignacio-Espinoza, J. C. et al. (2013) The global virome: not as big as we thought? Curr. Opin. Virol., 3, 566-571.
26. Kaspar, A. A. and Reichert, J. M. (2013) Future directions for peptide therapeutics development. Drug Discov. Today, 18, 807-817.
27. Koren, E. and Torchilin, V. P. (2012) Cell-penetrating peptides: breaking through to the other side. Trends Mol. Med., 18, 385-393.
28. Langedijk, J. P. M. (2002) Translocation activity of C-terminal domain of pestivirus Erns and ribotoxin L3 loop. J. Biol. Chem., 277, 5308-5314.
29. Langedijk, J. P. M. et al. (2004) New transport peptides broaden the horizon of applications for peptidic pharmaceuticals. Mol. Divers., 8, 101-111.
30. Ma, L. et al. (2004) Solution structure of dengue virus capsid protein reveals another fold. Proc. Natl Acad. Sci. USA, 101, 3414-3419.
31. Marchler-Bauer, A. et al. (2010) CDD: A Conserved Domain Database for the functional annotation of proteins. Nucleic Acids Res., 39, D225-D229.
32. Melo, M. N. et al. (2009) Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations. Nat. Rev. Microbiol., 7, 245-250.
33. Milletti, F. (2012) Cell-penetrating peptides: classes, origin, and current landscape. Drug Discov. Today, 17, 850-860.
34. Montrose, K. et al. (2013) Xentry, a new class of cell-penetrating peptide uniquely equipped for delivery of drugs. Sci. Rep., 3, 1661.
35. Nakase, I. et al. (2009) Cell-surface accumulation of flock house virus-derived peptide leads to efficient internalization via macropinocytosis. Mol. Ther., 17, 1868-1876.
36. Ouzounis, C. A. (2000) Global properties of the metabolic map of Escherichia coli. Genome Res., 10, 568-576.
37. Pierson, T. C. and Kielian, M. (2013) Flaviviruses: braking the entering. Curr. Opin. Virol., 3, 3-12.
38. Splith, K. and Neundorf, I. (2011) Antimicrobial peptides with cell-penetrating peptide properties and vice versa. Eur. Biophys. J., 40, 387-397.
39. The UniProt Consortium (2009) The Universal Protein Resource (UniProt) in 2010. Nucleic Acids Res., 38, D142-D148.
40. Torrent, M. et al. (2012) AMPA: An automated web server for prediction of protein antimicrobial regions. Bioinformatics, 28, 130-131.
41. Usme-Ciro, J. A. et al. (2013) Cytoplasmic RNA viruses as potential vehicles for the delivery of therapeutic small RNAs. Virol. J., 10, 185.
42. van den Berg, A. and Dowdy, S. F. (2011) Protein transduction domain delivery of therapeutic macromolecules. Curr. Opin. Biotechnol., 22, 888-893.
43. Vivès, E. et al. (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem., 272, 16010-16017.
44. Waghu, F. H. et al. (2014) CAMP: collection of sequences and structures of antimicrobial peptides. Nucleic Acids Res., 42, D1154-D1158.
45. Wilkins, M. R. et al. (1999) Protein identification and analysis tools in the ExPASy server. Methods Mol. Biol., 112, 531-552.
46. Zahid, M. and Robbins, P. D. (2012) Protein transduction domains: Applications for molecular medicine. Curr. Gene Ther., 12, 374-380.
47. Zasloff, M. (2002) Antimicrobial peptides of multicellular organisms. Nature, 415, 389-395.